Table of Contents Asia-Pacific Diabetic Therapeutic Drugs Market Report 2012-2023 1 Diabetic Therapeutic Drugs Overview 1.1 Product Overview and Scope of Diabetic Therapeutic Drugs 1.2 Classification of Diabetic Therapeutic Drugs by Product Category 1.2.1 Asia-Pacific Diabetic Therapeutic Drugs Sales (K Units) Comparison by Types (2012-2023) 1.2.2 Asia-Pacific Diabetic Therapeutic Drugs Sales (K Units) Market Share by Types in 2017 1.2.3 Insulin Therapies 1.2.4 Non-Insulin Therapies 1.3 Asia-Pacific Diabetic Therapeutic Drugs Market by Application/End Users 1.3.1 Asia-Pacific Diabetic Therapeutic Drugs (K Units) and Market Share Comparison by Applications (2012-2023) 1.3.2 Type 1 Diabetes 1.3.3 Type 2 Diabetes 1.3.4 Gestational Diabetes 1.4 Asia-Pacific Diabetic Therapeutic Drugs Market by Region 1.4.1 Asia-Pacific Diabetic Therapeutic Drugs Revenue (Million USD) Comparison by Regions (2012-2023) 1.4.2 China Status and Prospect (2012-2023) 1.4.3 Japan Status and Prospect (2012-2023) 1.4.4 South Korea Status and Prospect (2012-2023) 1.4.5 Taiwan Status and Prospect (2012-2023) 1.4.6 India Status and Prospect (2012-2023) 1.4.7 Southeast Asia Status and Prospect (2012-2023) 1.4.8 Australia Status and Prospect (2012-2023) 1.5 Asia-Pacific Sales and Revenue ofSales and Revenue of Diabetic Therapeutic Drugs (2012-2023) 1.5.1 Asia-Pacific Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2023) 1.5.2 Asia-Pacific Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) 2 Industrial Chain Analysis 2.1 Industry Chain Structure of Diabetic Therapeutic Drugs 2.2 Raw Material Analysis of Diabetic Therapeutic Drugs 2.1.1 Raw Material A Market Analysis 2.1.2 Raw Material B Market Analysis 2.1.3 Raw Material C Market Analysis 2.3 Labor Cost Analysis of K Units 2.4 Other Costs Analysis of Diabetic Therapeutic Drugs 2.5 Manufacturing Cost Structure Analysis of Diabetic Therapeutic Drugs 2.6 Manufacturing Process Analysis of Diabetic Therapeutic Drugs 2.7 Raw Materials Sources of Diabetic Therapeutic Drugs Major Manufacturers in 2018 2.8 Downstream Buyers 3 Asia-Pacific Diabetic Therapeutic Drugs Players/Suppliers Profiles and Sales Data 3.1 Pfizer 3.1.1 Company Basic Information, Manufacturing Base and Competitors 3.1.2 Diabetic Therapeutic Drugs Product Category, Application and Specification 3.1.2.1 Product A 3.1.2.2 Product B 3.1.3 Pfizer Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.1.4 Pfizer Different Types of Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.1.5 Pfizer Diabetic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.2 Novartis 3.2.1 Company Basic Information, Manufacturing Base and Competitors 3.2.2 Diabetic Therapeutic Drugs Product Category, Application and Specification 3.2.2.1 Product A 3.2.2.2 Product B 3.2.3 Novartis Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.2.4 Novartis Different Types of Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.2.5 Novartis Diabetic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.3 AstraZeneca 3.3.1 Company Basic Information, Manufacturing Base and Competitors 3.3.2 Diabetic Therapeutic Drugs Product Category, Application and Specification 3.3.2.1 Product A 3.3.2.2 Product B 3.3.3 AstraZeneca Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.3.4 AstraZeneca Different Types of Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.3.5 AstraZeneca Diabetic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.4 Eli Lilly 3.4.1 Company Basic Information, Manufacturing Base and Competitors 3.4.2 Diabetic Therapeutic Drugs Product Category, Application and Specification 3.4.2.1 Product A 3.4.2.2 Product B 3.4.3 Eli Lilly Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.4.4 Eli Lilly Different Types of Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.4.5 Eli Lilly Diabetic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.5 Merck 3.5.1 Company Basic Information, Manufacturing Base and Competitors 3.5.2 Diabetic Therapeutic Drugs Product Category, Application and Specification 3.5.2.1 Product A 3.5.2.2 Product B 3.5.3 Merck Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.5.4 Merck Different Types of Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.5.5 Merck Diabetic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.6 Novo Nordisk 3.6.1 Company Basic Information, Manufacturing Base and Competitors 3.6.2 Diabetic Therapeutic Drugs Product Category, Application and Specification 3.6.2.1 Product A 3.6.2.2 Product B 3.6.3 Novo Nordisk Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.6.4 Novo Nordisk Different Types of Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.6.5 Novo Nordisk Diabetic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.7 Sanofi 3.7.1 Company Basic Information, Manufacturing Base and Competitors 3.7.2 Diabetic Therapeutic Drugs Product Category, Application and Specification 3.7.2.1 Product A 3.7.2.2 Product B 3.7.3 Sanofi Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.7.4 Sanofi Different Types of Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.7.5 Sanofi Diabetic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.8 F. Hoffmann-La Roche 3.8.1 Company Basic Information, Manufacturing Base and Competitors 3.8.2 Diabetic Therapeutic Drugs Product Category, Application and Specification 3.8.2.1 Product A 3.8.2.2 Product B 3.8.3 F. Hoffmann-La Roche Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.8.4 F. Hoffmann-La Roche Different Types of Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.8.5 F. Hoffmann-La Roche Diabetic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.9 Takeda Pharmaceuticals 3.9.1 Company Basic Information, Manufacturing Base and Competitors 3.9.2 Diabetic Therapeutic Drugs Product Category, Application and Specification 3.9.2.1 Product A 3.9.2.2 Product B 3.9.3 Takeda Pharmaceuticals Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.9.4 Takeda Pharmaceuticals Different Types of Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.9.5 Takeda Pharmaceuticals Diabetic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.10 Sun Pharma 3.10.1 Company Basic Information, Manufacturing Base and Competitors 3.10.2 Diabetic Therapeutic Drugs Product Category, Application and Specification 3.10.2.1 Product A 3.10.2.2 Product B 3.10.3 Sun Pharma Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.10.4 Sun Pharma Different Types of Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.10.5 Sun Pharma Diabetic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.11 Perle Biosciences 3.12 Arbutus Biopharma 3.13 Belrose Pharma 3.14 Mitsubishi Tanabe Pharma 3.15 Dong-A ST 4 Asia-Pacific Diabetic Therapeutic Drugs Competition by Players/Manufacturers, Region, Type and Application 4.1 Asia-Pacific Diabetic Therapeutic Drugs Market Competition by Players/Manufacturers 4.1.1 Asia-Pacific Diabetic Therapeutic Drugs Sales (K Units) and Market Share of Key Players/Suppliers (2012-2017) 4.1.2 Asia-Pacific Diabetic Therapeutic Drugs Revenue (Million USD) and Share by Players/Suppliers (2012-2017) 4.2 Asia-Pacific Diabetic Therapeutic Drugs Sales and Revenue by Type 4.2.1 Asia-Pacific Diabetic Therapeutic Drugs Sales (K Units) and Market Share by Type (2012-2017) 4.2.2 Asia-Pacific Diabetic Therapeutic Drugs Revenue (Million USD) and Market Share by Type (2012-2017) 4.3 Asia-Pacific Diabetic Therapeutic Drugs Sales and Revenue by Application 4.3.1 Asia-Pacific Diabetic Therapeutic Drugs Sales (K Units) and Market Share by Regions (2012-2017) 4.3.2 Asia-Pacific Diabetic Therapeutic Drugs Revenue (Million USD) and Market Share (%) Regions (2012-2017) 4.4 Asia-Pacific Diabetic Therapeutic Drugs Sales (K Units) by Application 5 China Diabetic Therapeutic Drugs (Sales, Revenue and Price) 5.1 China Diabetic Therapeutic Drugs Sales and Value (2012-2017) 5.1.1 China Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) 5.1.2 China Diabetic Therapeutic Drugs Revenue and Growth Rate (2012-2017) 5.1.3 China Diabetic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) 5.2 China Diabetic Therapeutic Drugs Sales (K Units) and Market Share by Type 5.3 China Diabetic Therapeutic Drugs Sales (K Units) and Market Share by Application 6 Japan Diabetic Therapeutic Drugs (Sales, Revenue and Price) 6.1 Japan Diabetic Therapeutic Drugs Sales and Value (2012-2017) 6.1.1 Japan Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) 6.1.2 Japan Diabetic Therapeutic Drugs Revenue and Growth Rate (2012-2017) 6.1.3 Japan Diabetic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) 6.2 Japan Diabetic Therapeutic Drugs Sales (K Units) and Market Share by Type 6.3 Japan Diabetic Therapeutic Drugs Sales (K Units) and Market Share by Application 7 South Korea Diabetic Therapeutic Drugs (Sales, Revenue and Price) 7.1 South Korea Diabetic Therapeutic Drugs Sales and Value (2012-2017) 7.1.1 South Korea Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) 7.1.2 South Korea Diabetic Therapeutic Drugs Revenue and Growth Rate (2012-2017) 7.1.3 South Korea Diabetic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) 7.2 South Korea Diabetic Therapeutic Drugs Sales (K Units) and Market Share by Type 7.3 South Korea Diabetic Therapeutic Drugs Sales (K Units) and Market Share by Application 8 Taiwan Diabetic Therapeutic Drugs (Sales, Revenue and Price) 8.1 Taiwan Diabetic Therapeutic Drugs Sales and Value (2012-2017) 8.1.1 Taiwan Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) 8.1.2 Taiwan Diabetic Therapeutic Drugs Revenue and Growth Rate (2012-2017) 8.1.3 Taiwan Diabetic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) 8.2 Taiwan Diabetic Therapeutic Drugs Sales (K Units) and Market Share by Type 8.3 Taiwan Diabetic Therapeutic Drugs Sales (K Units) and Market Share by Application 9 India Diabetic Therapeutic Drugs (Sales, Revenue and Price) 9.1 India Diabetic Therapeutic Drugs Sales and Value (2012-2017) 9.1.1 India Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) 9.1.2 India Diabetic Therapeutic Drugs Revenue and Growth Rate (2012-2017) 9.1.3 India Diabetic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) 9.2 India Diabetic Therapeutic Drugs Sales (K Units) and Market Share by Type 9.3 India Diabetic Therapeutic Drugs Sales (K Units) and Market Share by Application 10 Southeast Asia Diabetic Therapeutic Drugs (Sales, Revenue and Price) 10.1 Southeast Asia Diabetic Therapeutic Drugs Sales and Value (2012-2017) 10.1.1 Southeast Asia Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) 10.1.2 Southeast Asia Diabetic Therapeutic Drugs Revenue and Growth Rate (2012-2017) 10.1.3 Southeast Asia Diabetic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) 10.2 Southeast Asia Diabetic Therapeutic Drugs Sales (K Units) and Market Share by Type 10.3 Southeast Asia Diabetic Therapeutic Drugs Sales (K Units) and Market Share by Application 11 Australia Diabetic Therapeutic Drugs (Sales, Revenue and Price) 11.1 Australia Diabetic Therapeutic Drugs Sales and Value (2012-2017) 11.1.1 Australia Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) 11.1.2 Australia Diabetic Therapeutic Drugs Revenue and Growth Rate (2012-2017) 11.1.3 Australia Diabetic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) 11.2 Australia Diabetic Therapeutic Drugs Sales (K Units) and Market Share by Type 11.3 Australia Diabetic Therapeutic Drugs Sales (K Units) and Market Share by Application 12 Marketing Strategy Analysis, Distributors/Traders 12.1 Direct Marketing 12.1.1 Direct Marketing 12.1.2 Indirect Marketing 12.1.3 Marketing Channel Development Trend 12.2 Market Positioning 12.2.1 Pricing Strategy 12.2.2 Brand Strategy 12.2.3 Target Client 12.3 Distributors/Traders List 13 Asia-Pacific Diabetic Therapeutic Drugs Market Forecast (2018-2023) 13.1 Asia-Pacific Diabetic Therapeutic Drugs Sales (K Units), Revenue and Price Forecast (2018-2023) 13.1.1 Asia-Pacific Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate Forecast (2018-2023) 13.1.2 Asia-Pacific Diabetic Therapeutic Drugs Revenue and Growth Rate Forecast (2018-2023) 13.1.3 Asia-Pacific Diabetic Therapeutic Drugs Price and Trend Forecast (2018-2023) 13.2 Asia-Pacific Diabetic Therapeutic Drugs Sales (K Units), Revenue and Growth Rate Forecast by Region (2018-2023) 13.2.1 Asia-Pacific Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate Forecast by Region (2018-2023) 13.2.2 Asia-Pacific Diabetic Therapeutic Drugs Revenue and Growth Rate Forecast by Region (2018-2023) 13.2.3 China Diabetic Therapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.4 Japan Diabetic Therapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.5 South Korea Diabetic Therapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.6 Taiwan Diabetic Therapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.7 South Korea Diabetic Therapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.8 Southeast Asia Diabetic Therapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.9 Australia Diabetic Therapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.3 Asia-Pacific Diabetic Therapeutic Drugs Sales, Revenue and Price Forecast by Type (2018-2023) 13.3.1 Asia-Pacific Diabetic Therapeutic Drugs Sales Forecast by Type (2018-2023) 13.3.2 Asia-Pacific Diabetic Therapeutic Drugs Revenue Forecast by Type (2018-2023) 13.3.3 Asia-Pacific Diabetic Therapeutic Drugs Price Forecast by Type (2018-2023) 13.4 Asia-Pacific Diabetic Therapeutic Drugs Sales Forecast by Application (2018-2023) 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology/Research Approach 15.1.1 Research Programs/Design 15.1.2 Market Size Estimation 15.1.3 Market Breakdown and Data Triangulation 15.2 Data Source 15.2.1 Secondary Sources 15.2.2 Primary Sources 15.3 Disclaimer

List of Tables and Figures Figure Asia-Pacific Market Size (Million USD) Comparison 2012-2023 Table Asia-Pacific Market Diabetic Therapeutic Drugs Revenue (Million USD) Comparison by Regions 2012-2023 Table Asia-Pacific Diabetic Therapeutic Drugs Sales (K Units) and Revenue (Million USD) Market Split by Product Type Table Asia-Pacific Diabetic Therapeutic Drugs Sales (K Units) by Application (2016-2023) Figure Product Picture of Diabetic Therapeutic Drugs Table Asia-Pacific Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (%) Comparison by Types (2012-2023) Figure Asia-Pacific Diabetic Therapeutic Drugs Sales (K Units) Market Share by Types in 2017 Figure Insulin Therapies Picture Figure Non-Insulin Therapies Picture Table Asia-Pacific Diabetic Therapeutic Drugs Sales (K Units) Comparison by Applications (2012-2023) Figure Asia-Pacific Sales Market Share of Diabetic Therapeutic Drugs by Applications in 2017 Figure Type 1 Diabetes Picture Figure Type 2 Diabetes Picture Figure Gestational Diabetes Picture Table Asia-Pacific Market Diabetic Therapeutic Drugs Revenue (Million USD) Comparison by Regions 2012-2023 Figure China Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Japan Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure South Korea Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Taiwan Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure India Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Southeast Asia Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Australia Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Asia-Pacific Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2023) Figure Asia-Pacific Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure New Project SWOT Analysis of Diabetic Therapeutic Drugs Table Industry News List of Diabetic Therapeutic Drugs Figure Industry Chain Structure of Diabetic Therapeutic Drugs Table Raw Material Suppliers and Price Analysis Figure Global Raw Material A Price Trend (USD/MT) Figure Global Raw Material B Price Trend (USD/MT) Figure Global Raw Material C Price Trend (USD/MT) Table Manufacturing Cost Structure Analysis of Diabetic Therapeutic Drugs in 2017 Figure Manufacturing Process Analysis of Diabetic Therapeutic Drugs Table Raw Materials Sources of Diabetic Therapeutic Drugs Major Manufacturers in 2017 Table Major Buyers of Diabetic Therapeutic Drugs Table Pfizer Basic Information List Table Pfizer Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Pfizer Diabetic Therapeutic Drugs Sales Growth Rate (2012-2017) Figure Pfizer Diabetic Therapeutic Drugs Sales Asia-Pacific Market Share (%) (2012-2017) Figure Pfizer Diabetic Therapeutic Drugs Revenue Asia-Pacific Market Share (%) (2012-2017) Table Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Non-Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Pfizer Diabetic Therapeutic Drugs Volume in Type 1 Diabetes and Its Application Share Table Pfizer Diabetic Therapeutic Drugs Volume in Type 2 Diabetes and Its Application Share Table Pfizer Diabetic Therapeutic Drugs Volume in Gestational Diabetes and Its Application Share Table Novartis Basic Information List Table Novartis Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Novartis Diabetic Therapeutic Drugs Sales Growth Rate (2012-2017) Figure Novartis Diabetic Therapeutic Drugs Sales Asia-Pacific Market Share (%) (2012-2017) Figure Novartis Diabetic Therapeutic Drugs Revenue Asia-Pacific Market Share (%) (2012-2017) Table Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Non-Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Novartis Diabetic Therapeutic Drugs Volume in Type 1 Diabetes and Its Application Share Table Novartis Diabetic Therapeutic Drugs Volume in Type 2 Diabetes and Its Application Share Table Novartis Diabetic Therapeutic Drugs Volume in Gestational Diabetes and Its Application Share Table AstraZeneca Basic Information List Table AstraZeneca Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure AstraZeneca Diabetic Therapeutic Drugs Sales Growth Rate (2012-2017) Figure AstraZeneca Diabetic Therapeutic Drugs Sales Asia-Pacific Market Share (%) (2012-2017) Figure AstraZeneca Diabetic Therapeutic Drugs Revenue Asia-Pacific Market Share (%) (2012-2017) Table Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Non-Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table AstraZeneca Diabetic Therapeutic Drugs Volume in Type 1 Diabetes and Its Application Share Table AstraZeneca Diabetic Therapeutic Drugs Volume in Type 2 Diabetes and Its Application Share Table AstraZeneca Diabetic Therapeutic Drugs Volume in Gestational Diabetes and Its Application Share Table Eli Lilly Basic Information List Table Eli Lilly Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Eli Lilly Diabetic Therapeutic Drugs Sales Growth Rate (2012-2017) Figure Eli Lilly Diabetic Therapeutic Drugs Sales Asia-Pacific Market Share (%) (2012-2017) Figure Eli Lilly Diabetic Therapeutic Drugs Revenue Asia-Pacific Market Share (%) (2012-2017) Table Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Non-Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Eli Lilly Diabetic Therapeutic Drugs Volume in Type 1 Diabetes and Its Application Share Table Eli Lilly Diabetic Therapeutic Drugs Volume in Type 2 Diabetes and Its Application Share Table Eli Lilly Diabetic Therapeutic Drugs Volume in Gestational Diabetes and Its Application Share Table Merck Basic Information List Table Merck Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Merck Diabetic Therapeutic Drugs Sales Growth Rate (2012-2017) Figure Merck Diabetic Therapeutic Drugs Sales Asia-Pacific Market Share (%) (2012-2017) Figure Merck Diabetic Therapeutic Drugs Revenue Asia-Pacific Market Share (%) (2012-2017) Table Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Non-Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Merck Diabetic Therapeutic Drugs Volume in Type 1 Diabetes and Its Application Share Table Merck Diabetic Therapeutic Drugs Volume in Type 2 Diabetes and Its Application Share Table Merck Diabetic Therapeutic Drugs Volume in Gestational Diabetes and Its Application Share Table Novo Nordisk Basic Information List Table Novo Nordisk Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Novo Nordisk Diabetic Therapeutic Drugs Sales Growth Rate (2012-2017) Figure Novo Nordisk Diabetic Therapeutic Drugs Sales Asia-Pacific Market Share (%) (2012-2017) Figure Novo Nordisk Diabetic Therapeutic Drugs Revenue Asia-Pacific Market Share (%) (2012-2017) Table Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Non-Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Novo Nordisk Diabetic Therapeutic Drugs Volume in Type 1 Diabetes and Its Application Share Table Novo Nordisk Diabetic Therapeutic Drugs Volume in Type 2 Diabetes and Its Application Share Table Novo Nordisk Diabetic Therapeutic Drugs Volume in Gestational Diabetes and Its Application Share Table Sanofi Basic Information List Table Sanofi Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Sanofi Diabetic Therapeutic Drugs Sales Growth Rate (2012-2017) Figure Sanofi Diabetic Therapeutic Drugs Sales Asia-Pacific Market Share (%) (2012-2017) Figure Sanofi Diabetic Therapeutic Drugs Revenue Asia-Pacific Market Share (%) (2012-2017) Table Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Non-Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Sanofi Diabetic Therapeutic Drugs Volume in Type 1 Diabetes and Its Application Share Table Sanofi Diabetic Therapeutic Drugs Volume in Type 2 Diabetes and Its Application Share Table Sanofi Diabetic Therapeutic Drugs Volume in Gestational Diabetes and Its Application Share Table F. Hoffmann-La Roche Basic Information List Table F. Hoffmann-La Roche Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure F. Hoffmann-La Roche Diabetic Therapeutic Drugs Sales Growth Rate (2012-2017) Figure F. Hoffmann-La Roche Diabetic Therapeutic Drugs Sales Asia-Pacific Market Share (%) (2012-2017) Figure F. Hoffmann-La Roche Diabetic Therapeutic Drugs Revenue Asia-Pacific Market Share (%) (2012-2017) Table Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Non-Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table F. Hoffmann-La Roche Diabetic Therapeutic Drugs Volume in Type 1 Diabetes and Its Application Share Table F. Hoffmann-La Roche Diabetic Therapeutic Drugs Volume in Type 2 Diabetes and Its Application Share Table F. Hoffmann-La Roche Diabetic Therapeutic Drugs Volume in Gestational Diabetes and Its Application Share Table Takeda Pharmaceuticals Basic Information List Table Takeda Pharmaceuticals Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Takeda Pharmaceuticals Diabetic Therapeutic Drugs Sales Growth Rate (2012-2017) Figure Takeda Pharmaceuticals Diabetic Therapeutic Drugs Sales Asia-Pacific Market Share (%) (2012-2017) Figure Takeda Pharmaceuticals Diabetic Therapeutic Drugs Revenue Asia-Pacific Market Share (%) (2012-2017) Table Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Non-Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Takeda Pharmaceuticals Diabetic Therapeutic Drugs Volume in Type 1 Diabetes and Its Application Share Table Takeda Pharmaceuticals Diabetic Therapeutic Drugs Volume in Type 2 Diabetes and Its Application Share Table Takeda Pharmaceuticals Diabetic Therapeutic Drugs Volume in Gestational Diabetes and Its Application Share Table Company Sun Pharma Basic Information List Table Company Sun Pharma Diabetic Therapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Company Sun Pharma Diabetic Therapeutic Drugs Sales Growth Rate (2012-2017) Figure Company Sun Pharma Diabetic Therapeutic Drugs Sales Asia-Pacific Market Share (%) (2012-2017) Figure Company Sun Pharma Diabetic Therapeutic Drugs Revenue Asia-Pacific Market Share (%) (2012-2017) Table Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Non-Insulin Therapies Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Sales (K Units), Revenue (Million USD) and Price (USD/Unit)(2012-2017) Table Company Sun Pharma Diabetic Therapeutic Drugs Volume in Type 1 Diabetes and Its Application Share Table Company Sun Pharma Diabetic Therapeutic Drugs Volume in Type 2 Diabetes and Its Application Share Table Company Sun Pharma Diabetic Therapeutic Drugs Volume in Gestational Diabetes and Its Application Share Table Asia-Pacific Diabetic Therapeutic Drugs Sales (K Units) by Players/Manufacturers (2012-2017) Table Asia-Pacific Diabetic Therapeutic Drugs Sales Share (%) by Players/Manufacturers (2012-2017) Figure 2016 Asia-Pacific Diabetic Therapeutic Drugs Sales Market Share (%) by Players/Manufacturers Figure 2017 Asia-Pacific Diabetic Therapeutic Drugs Sales Share by Players/Manufacturers Table Asia-Pacific Diabetic Therapeutic Drugs Revenue (Million USD) by Players/Manufacturers (2012-2017) Table Asia-Pacific Diabetic Therapeutic Drugs Revenue Market Share (%) Players/Manufacturers (2012-2017) Figure 2016 Asia-Pacific Diabetic Therapeutic Drugs Revenue Market Share (%) Players Figure 2017 Asia-Pacific Diabetic Therapeutic Drugs Revenue Market Share (%) Players Table Asia-Pacific Diabetic Therapeutic Drugs Sales (K Units) and Market Share (%) by Type (2012-2017) Table Asia-Pacific Diabetic Therapeutic Drugs Sales Share by Type (2012-2017) Figure Sales Market Share of Diabetic Therapeutic Drugs by Type (2012-2017) Figure Asia-Pacific Diabetic Therapeutic Drugs Sales Growth Rate (%) by Type (2012-2017) Table Asia-Pacific Diabetic Therapeutic Drugs Revenue (Million USD) and Market Share (%) Type (2012-2017) Table Asia-Pacific Diabetic Therapeutic Drugs Revenue Market Share (%) Type (2012-2017) Figure Revenue Market Share of Diabetic Therapeutic Drugs by Type (2012-2017) Figure Asia-Pacific Diabetic Therapeutic Drugs Revenue Growth Rate by Type (2012-2017) Table Asia-Pacific Diabetic Therapeutic Drugs Sales (K Units) and Market Share by Regions (2012-2017) Table Asia-Pacific Diabetic Therapeutic Drugs Sales Share by Regions (2012-2017) Figure Sales Market Share of Diabetic Therapeutic Drugs by Regions (2012-2017) Figure Asia-Pacific Diabetic Therapeutic Drugs Sales Market Share by Regions in 2017 Table Asia-Pacific Diabetic Therapeutic Drugs Revenue (Million USD) and Market Share by Regions (2012-2017) Table Asia-Pacific Diabetic Therapeutic Drugs Revenue Share (%) by Regions (2012-2017) Figure Revenue Market Share of Diabetic Therapeutic Drugs by Regions (2012-2017) Figure Asia-Pacific Diabetic Therapeutic Drugs Revenue Market Share by Regions in 2017 Table Asia-Pacific Diabetic Therapeutic Drugs Sales (K Units) and Market Share by Application (2012-2017) Table Asia-Pacific Diabetic Therapeutic Drugs Sales Share (%) by Application (2012-2017) Figure Asia-Pacific Diabetic Therapeutic Drugs Sales Market Share by Application (2012-2017) Figure Asia-Pacific Diabetic Therapeutic Drugs Sales Market Share by Application (2012-2017) Figure China Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (%) (2012-2017) Figure China Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure China Diabetic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) Table China Diabetic Therapeutic Drugs Sales (K Units) by Type (2012-2017) Table China Diabetic Therapeutic Drugs Sales (K Units) Market Share by Type (2012-2017) Figure China Diabetic Therapeutic Drugs Sales (K Units) Market Share by Type in 2017 Table China Diabetic Therapeutic Drugs Sales (K Units) by Applications (2012-2017) Table China Diabetic Therapeutic Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure China Diabetic Therapeutic Drugs Sales (K Units) Market Share by Applications in 2017 Figure Japan Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Japan Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Japan Diabetic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Japan Diabetic Therapeutic Drugs Sales (K Units) by Type (2012-2017) Table Japan Diabetic Therapeutic Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Japan Diabetic Therapeutic Drugs Sales (K Units) Market Share by Type in 2017 Table Japan Diabetic Therapeutic Drugs Sales (K Units) by Applications (2012-2017) Table Japan Diabetic Therapeutic Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Japan Diabetic Therapeutic Drugs Sales (K Units) Market Share by Applications in 2017 Figure South Korea Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) Figure South Korea Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure South Korea Diabetic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) Table South Korea Diabetic Therapeutic Drugs Sales (K Units) by Type (2012-2017) Table South Korea Diabetic Therapeutic Drugs Sales (K Units) Market Share by Type (2012-2017) Figure South Korea Diabetic Therapeutic Drugs Sales (K Units) Market Share by Type in 2017 Table South Korea Diabetic Therapeutic Drugs Sales (K Units) by Applications (2012-2017) Table South Korea Diabetic Therapeutic Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure South Korea Diabetic Therapeutic Drugs Sales (K Units) Market Share by Applications in 2017 Figure Taiwan Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Taiwan Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Taiwan Diabetic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Taiwan Diabetic Therapeutic Drugs Sales (K Units) by Type (2012-2017) Table Taiwan Diabetic Therapeutic Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Taiwan Diabetic Therapeutic Drugs Sales (K Units) Market Share by Type in 2017 Table Taiwan Diabetic Therapeutic Drugs Sales (K Units) by Applications (2012-2017) Table Taiwan Diabetic Therapeutic Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Taiwan Diabetic Therapeutic Drugs Sales (K Units) Market Share by Applications in 2017 Figure Southeast Asia Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Southeast Asia Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Southeast Asia Diabetic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Southeast Asia Diabetic Therapeutic Drugs Sales (K Units) by Type (2012-2017) Table Southeast Asia Diabetic Therapeutic Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Southeast Asia Diabetic Therapeutic Drugs Sales (K Units) Market Share by Type in 2017 Table Southeast Asia Diabetic Therapeutic Drugs Sales (K Units) by Applications (2012-2017) Table Southeast Asia Diabetic Therapeutic Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Southeast Asia Diabetic Therapeutic Drugs Sales (K Units) Market Share by Applications in 2017 Figure India Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) Figure India Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure India Diabetic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) Table India Diabetic Therapeutic Drugs Sales (K Units) by Type (2012-2017) Table India Diabetic Therapeutic Drugs Sales (K Units) Market Share by Type (2012-2017) Figure India Diabetic Therapeutic Drugs Sales (K Units) Market Share by Type in 2017 Table India Diabetic Therapeutic Drugs Sales (K Units) by Applications (2012-2017) Table India Diabetic Therapeutic Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure India Diabetic Therapeutic Drugs Sales (K Units) Market Share by Applications in 2017 Figure Australia Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Australia Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Australia Diabetic Therapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Australia Diabetic Therapeutic Drugs Sales (K Units) by Type (2012-2017) Table Australia Diabetic Therapeutic Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Australia Diabetic Therapeutic Drugs Sales (K Units) Market Share by Type in 2017 Table Australia Diabetic Therapeutic Drugs Sales (K Units) by Applications (2012-2017) Table Australia Diabetic Therapeutic Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Australia Diabetic Therapeutic Drugs Sales (K Units) Market Share by Applications in 2017 Table Distributors/Traders List Figure Asia-Pacific Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate Forecast (2018-2023) Figure Asia-Pacific Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Asia-Pacific Diabetic Therapeutic Drugs Price and Trend Forecast (2018-2023) Table Asia-Pacific Diabetic Therapeutic Drugs Sales (K Units) Forecast by Regions (2018-2023) Figure Asia-Pacific Diabetic Therapeutic Drugs Sales (K Units) Market Share Forecast by Regions (2018-2023) Figure Asia-Pacific Diabetic Therapeutic Drugs Sales (K Units) Market Share Forecast by Regions in 2023 Table Asia-Pacific Diabetic Therapeutic Drugs Revenue (Million USD) Forecast by Regions (2018-2023) Figure Asia-Pacific Diabetic Therapeutic Drugs Revenue Market Share Forecast by Regions (2018-2023) Figure Asia-Pacific Diabetic Therapeutic Drugs Revenue Market Share Forecast by Regions in 2023 Figure China Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure China Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure South Korea Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure South Korea Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Japan Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Japan Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Taiwan Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Taiwan Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure India Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure India Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Southeast Asia Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Southeast Asia Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Australia Diabetic Therapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Australia Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Table Asia-Pacific Diabetic Therapeutic Drugs Sales (K Units) Forecast by Type (2018-2023) Figure Asia-Pacific Diabetic Therapeutic Drugs Sales Market Share Forecast by Type (2018-2023) Table Asia-Pacific Diabetic Therapeutic Drugs Revenue (Million USD) Forecast by Type (2018-2023) Figure Asia-Pacific Diabetic Therapeutic Drugs Revenue Market Share Forecast by Type (2018-2023) Table Asia-Pacific Diabetic Therapeutic Drugs Price (USD/Unit) Forecast by Type (2018-2023) Table Asia-Pacific Diabetic Therapeutic Drugs Sales (K Units) Forecast by Application (2018-2023) Figure Asia-Pacific Diabetic Therapeutic Drugs Sales Market Share Forecast by Application (2018-2023) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Pfizer Novartis AstraZeneca Eli Lilly Merck Novo Nordisk Sanofi F. Hoffmann-La Roche Takeda Pharmaceuticals Sun Pharma Perle Biosciences Arbutus Biopharma Belrose Pharma Mitsubishi Tanabe Pharma Dong-A ST